Formyl peptide receptors as mediators of intestinal mucosal homeostasis

甲酰基肽受体作为肠粘膜稳态调节剂

基本信息

  • 批准号:
    8066189
  • 负责人:
  • 金额:
    $ 49.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-09-01 至 2015-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The gastrointestinal epithelium functions as a dynamic barrier that serves as an interface between luminal contents and underlying tissue compartments, and is thus vital in maintaining mucosal homeostasis. Mucosal wounds have been observed following enteric infection, inflammatory bowel disease and ischemic insults. Disruption of the critical epithelial barrier allows access of luminal contents to immunologically privileged compartments thereby contributing to disease pathogenesis. In response to injury, intestinal epithelial cells (IEC) migrate and proliferate to rapidly cover denuded surfaces and re-establish the epithelia barrier. We have recently identified expression of the N-formyl peptide receptors (FPR1 and FPR2) in the intestinal epithelium. Our studies determined that a bacterial derived N-formyl peptide, fMLF and the endogenous Annexin 1 protein, which are agonists for FPR family members, promote intestinal epithelial cell migration and facilitate wound closure. Additionally, it is becoming evident that a healthy optimized intestinal microflora mediates important roles in normal gut homeostasis and recovery from mucosal insults. Recent experimental results in our laboratory revealed that epithelial cells exposed to fMLF and intact bacteria also rapidly initiate cytoplasmic signaling events, Rac and Cdc2 activation, reactive oxygen species (ROS) production, epithelial cell migration and wound closure. Thus, we believe that FPRs represent important novel type of pattern recognition receptors (PRR) in the intestinal epithelium that transmit homeostatic signaling and facilitate epithelial barrier recovery following pathologic insults. Thus, our overall objectives are to define the pathobiologic function of epithelial FPRs and microbiota in regulating intestinal homeostasis, barrier recovery and resolution of inflammation. PUBLIC HEALTH RELEVANCE: Intestinal epithelial injury occurs in a wide spectrum of clinical conditions that include inflammatory bowel diseases, enteric infection, ischemia and following surgical procedures. The loss of epithelial barrier function associated with injury contributes to mucosal inflammation. Numerous physiological processes including those influenced by the normal prokaryotic microbiota have been implicated in regulating intestinal epithelial homeostasis. Thus, given the pathologic ramifications of epithelial injury, it is vital to understand mechanisms of intestinal epithelial barrier maintenance/recovery and in defining the role of microbiota in these processes. We propose the formyl peptide receptors (FPRs) as novel pattern recognition receptors that regulate intestinal epithelial growth, motility and restitution post injury, as well as the positive influence of the microbiota in these events. Realization of the role of FPRs and their ligands on epithelial barrier regulation and wound recovery will facilitate in development of therapeutic agents to promote regeneration of the intestinal mucosa.
描述(由申请人提供):胃肠上皮的功能充当动态屏障,它是腔内内容物和基础组织室之间的界面,因此对于维持粘膜稳态至关重要。肠道感染,炎症性肠病和缺血性损伤后,已经观察到粘膜伤口。临界上皮屏障的破坏允许将腔内容物访问免疫特权隔室,从而有助于疾病发病机理。为了响应损伤,肠上皮细胞(IEC)迁移并增殖至迅速覆盖的表面并重新建立上皮屏障。我们最近鉴定了肠上皮中N-甲基肽受体(FPR1和FPR2)的表达。我们的研究确定,细菌衍生的N-甲基甲基肽FMLF和内源性膜剂1蛋白是FPR家族成员的激动剂,促进肠上皮细胞迁移并促进伤口闭合。此外,越来越明显的是,健康优化的肠道菌群在正常的肠道稳态中介导了重要的作用,并从粘膜损伤中恢复。我们实验室的最新实验结果表明,暴露于FMLF和完整细菌的上皮细胞也迅速引发了细胞质信号事件,RAC和CDC2激活,活性氧(ROS)产生,上皮细胞迁移和伤口闭合。因此,我们认为FPR代表了肠上皮中重要的新型模式识别受体(PRR),该类型是在病理侮辱后传递稳态信号传导并促进上皮屏障恢复的重要类型。因此,我们的总体目标是定义上皮FPR和微生物群在调节肠道稳态,障碍恢复和炎症的分辨率方面的病理生物学功能。 公共卫生相关性:肠上皮损伤发生在各种临床疾病中,包括炎症性肠病,肠道感染,缺血以及遵循手术程序。与损伤相关的上皮屏障功能的丧失会导致粘膜炎症。许多生理过程,包括受正常核核微生物群影响的生理过程已与调节肠上皮稳态有关。因此,鉴于上皮损伤的病理影响,了解肠上皮屏障维持/恢复的机制以及定义微生物群在这些过程中的作用时至关重要。我们将甲基肽受体(FPR)作为新型模式识别受体,这些受体调节肠上皮生长,运动能力和损伤后的恢复性,以及在这些事件中菌群的积极影响。 FPR及其配体在上皮屏障调节和伤口恢复方面的作用的实现将有助于开发治疗剂,以促进肠粘膜再生。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ASMA NUSRAT其他文献

ASMA NUSRAT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ASMA NUSRAT', 18)}}的其他基金

Polarity proteins and intestinal mucosal responses to inflammation and injury
极性蛋白和肠粘膜对炎症和损伤的反应
  • 批准号:
    10442201
  • 财政年份:
    2022
  • 资助金额:
    $ 49.53万
  • 项目类别:
Polarity proteins and intestinal mucosal responses to inflammation and injury
极性蛋白和肠粘膜对炎症和损伤的反应
  • 批准号:
    10598126
  • 财政年份:
    2022
  • 资助金额:
    $ 49.53万
  • 项目类别:
Formyl peptide receptors as mediators of intestinal mucosal homeostasis
甲酰基肽受体作为肠粘膜稳态调节剂
  • 批准号:
    9181392
  • 财政年份:
    2015
  • 资助金额:
    $ 49.53万
  • 项目类别:
Formyl peptide receptors as mediators of intestinal mucosal homeostasis
甲酰基肽受体作为肠粘膜稳态调节剂
  • 批准号:
    9010350
  • 财政年份:
    2015
  • 资助金额:
    $ 49.53万
  • 项目类别:
FASEB SRC on Gastrointestinal Tract XV: Epithelia, Microbes, Inflammation and Can
FASEB SRC 关于胃肠道 XV:上皮、微生物、炎症和罐头病
  • 批准号:
    8525712
  • 财政年份:
    2013
  • 资助金额:
    $ 49.53万
  • 项目类别:
2012 Annual Meeting of the American Society for Investigative Pathology
2012年美国病理研究学会年会
  • 批准号:
    8317861
  • 财政年份:
    2012
  • 资助金额:
    $ 49.53万
  • 项目类别:
Intestinal Epithelial Tight Junction Structure-Function
肠上皮紧密连接结构-功能
  • 批准号:
    8538941
  • 财政年份:
    2011
  • 资助金额:
    $ 49.53万
  • 项目类别:
Intestinal Epithelial Tight Junction Structure-Function
肠上皮紧密连接结构-功能
  • 批准号:
    8325536
  • 财政年份:
    2011
  • 资助金额:
    $ 49.53万
  • 项目类别:
Formyl peptide receptors as mediators of intestinal mucosal homeostasis
甲酰基肽受体作为肠粘膜稳态调节剂
  • 批准号:
    8667429
  • 财政年份:
    2011
  • 资助金额:
    $ 49.53万
  • 项目类别:
Intestinal Epithelial Tight Junction Structure-Function
肠上皮紧密连接结构-功能
  • 批准号:
    8720748
  • 财政年份:
    2011
  • 资助金额:
    $ 49.53万
  • 项目类别:

相似国自然基金

线粒体ClpP激动剂通过铁死亡-免疫调控cross-talk治疗急性髓细胞白血病的机制研究
  • 批准号:
    82370171
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
基于FACS的AT1R偏向性激动剂的超高通量筛选
  • 批准号:
    31600628
  • 批准年份:
    2016
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目
PPAR-α激动剂在急性心肌梗死中调控巨噬细胞极化促进血管生成的机制研究
  • 批准号:
    81500267
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
应用芳香羟受体激动剂FICZ预防小鼠急性移植物抗宿主病的机制研究
  • 批准号:
    81500151
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Rhinovirus, airway smooth muscle, and mechanisms of irreversible airflow obstruction
鼻病毒、气道平滑肌和不可逆气流阻塞机制
  • 批准号:
    10735460
  • 财政年份:
    2023
  • 资助金额:
    $ 49.53万
  • 项目类别:
Evaluation of anti-fibrotic and anti-inflammatory semi-synthetic oxysterol, Oxy210, as a therapeutic drug candidate for non-alcoholic steatohepatitis
抗纤维化和抗炎半合成氧甾醇 Oxy210 作为非酒精性脂肪性肝炎候选治疗药物的评价
  • 批准号:
    10697132
  • 财政年份:
    2023
  • 资助金额:
    $ 49.53万
  • 项目类别:
The role of circadian clock proteins in innate and adaptive immunity
生物钟蛋白在先天性和适应性免疫中的作用
  • 批准号:
    10582781
  • 财政年份:
    2022
  • 资助金额:
    $ 49.53万
  • 项目类别:
The role of circadian clock proteins in innate and adaptive immunity
生物钟蛋白在先天性和适应性免疫中的作用
  • 批准号:
    10892546
  • 财政年份:
    2022
  • 资助金额:
    $ 49.53万
  • 项目类别:
Role of the Rac1-GEF Tiam1 in Synaptic Plasticity and Hippocampal-Dependent Learning and Memory
Rac1-GEF Tiam1 在突触可塑性和海马依赖性学习和记忆中的作用
  • 批准号:
    10403424
  • 财政年份:
    2021
  • 资助金额:
    $ 49.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了